Management Team

Markus Pompejus, Chief Executive Officer

Dirk Daems, Vice President of Business Operations

Ken Barrett, Vice President of Business Development & Strategy

Kevin Bracken, Vice President of Manufacturing

Brian Carter, Vice President of Grain Processing

Cate Scanlon, Vice President of Human Resources

Mark Wall, Vice President of R&D Operations

David Weiner, Vice President of R&D Strategy, Innovation & Partnerships

 back to top

Markus Pompejus
Chief Executive Officer

Markus Pompejus became Chief Executive Officer of Verenium Corporation in January 2014 following the acquisition of Verenium Corporation by BASF in November 2013. Markus joined BASF in 1996 and has held various leadership roles in Germany, South Korea and the United States, including Research and Development for Biotech and Materials, Manufacturing and Large Scale Fermentation, Planning and Coordination, and Business Development. Currently Markus leads BASF’s research group for white biotechnology in North America.  Markus earned a Ph.D. in Biology with a focus on Microbiology/Biochemistry /Biotechnology from the University of Goettingen, Germany.

 back to top

Dirk DaemsDirk Daems
Vice President, Business Operations

Dirk Daems became Vice-President Business Operations of Verenium Corporation in April 2014 following the acquisition of Verenium Corporation by BASF in November 2013. Dirk joined BASF in 2009 through BASF’s acquisition of the Polyurethanes specialties Business for Car window Encapsulation from Recticel and has served for BASF in several management capacities in business Integration, Business Development Innovation. Prior to joining BASF, Dirk has worked in Belgium, Germany and since 1995 in the U.S.A in different roles including Business Development, Technology Management, Plant-Launches and Operations in general as well Executive Management including all functional areas.
Dirk holds a Bachelor Degree in Chemical Engineering and an MBA from the University of Leuven in Belgium.

 back to top

Ken Barrett
Vice President, Business Development & Strategy

Ken Barrett joined Verenium in August 2006 as Associate Director of Business Development responsible for supporting the Company's commercialization strategy with a focus on developing internal capabilities and launching new products. In 2008, Mr. Barrett was promoted to Director of Business Development and in 2010 he was promoted to his current position, in which he leads the Company's strategy and business development efforts.  Prior to joining Verenium, Mr. Barrett was a co-Founder and Managing Director of Trident Partners, LLC, a private equity and management firm focused on small and medium sized businesses which differentiated itself by direct involvement in operations and strategy development of its acquisitions.  Before that, Mr. Barrett served as a consultant at Bain & Company developing and applying analytical frameworks and generating insights and results for client businesses.  He began his career at Mitsubishi Motors Corporation in 1989 in Japan. Mr. Barrett received a M.S. in Applied Biosciences from the University of Arizona in Tucson, Arizona, a M.B.A. degree from Harvard Business School in Boston, Massachusetts and a B.A. in Engineering Sciences from Dartmouth College in Hanover, New Hampshire.

 back to top

Kevin Bracken
Vice President, Manufacturing

Kevin Bracken joined Verenium in August 2010 as Vice President of Manufacturing.  Prior to joining Verenium, Mr. Bracken was Vice President of Manufacturing at Vical Incorporated, a developer of biopharmaceutical products, where he was responsible for all manufacturing activities, served on numerous product development, validation and technical teams for new product candidates, and supervised all scale-up and optimization operations for the company.  Before that Mr. Bracken was Vice President of Process Engineering and Manufacturing at Universal Preservation Technologies, Inc., and was Director of Engineering for Molecular Biosystems. Prior to that, he held positions of increasing responsibility in process engineering with Gilead Sciences and Baxter International.  Mr. Bracken began his career as an engineer with DuPont. Mr. Bracken received a B.S. in Chemical Engineering from the University of Delaware and a M.S. in Chemical Engineering from the University of Rochester.

 back to top

Brian Carter
Vice President, Grain Processing

Brian Carter joined Verenium in September 2012 as Vice President of Business Development and was appointed to the position of Vice President of Grain Processing in April 2013.  Mr. Carter is responsible for driving the growth and overall performance of Verenium's Grain Processing business. Prior to joining Verenium, Mr. Carter spent nearly 20 years at Genencor, now part of DuPont Industrial Biosciences, where he held a variety of senior leadership roles in business development and general management.   Mr. Carter received a B.S. degree in Business Management from James Madison University in Harrisonburg, Virginia.

 back to top

Cate Scanlon
Vice President, Human Resources

Catherine Scanlon became Vice President, Human Resources in February 2012. She joined Verenium in September 2007 as Sr. Manager, became Director in August 2010 and head of human resources in March 2011. Prior to joining Verenium, Ms. Scanlon held several positions with increasing responsibility, including Director of Human Resources, at Cambridge Energy Research Associates, Inc. (now a division of IHS, Inc.) a leading energy strategy and consulting firm in Cambridge, Massachusetts. Ms. Scanlon received a Masters in Counseling Psychology from Boston College, Boston, Massachusetts and a Bachelors degree in English from Canisius College, Buffalo, New York. Ms. Scanlon also holds certifications as a Senior Human Resources Professional (SPHR) and a Certified Compensation Professional (CCP).

 back to top

Mark Wall
Vice President, R&D Operations

Mark Wall joined Verenium in 2002, and has served in a variety of roles in R&D including genome sequencing as well as project and technology development in enzymes, biofuels and protein therapeutics. He became Vice President of R&D Operations in August of 2011. Throughout his tenure at Verenium, Dr. Wall has been a member on various coordinating boards which have been responsible for project execution and scientific development, and he was principal investigator on an NIH grant to improve antibody function. Dr. Wall has over 19 years postgraduate experience in structural biology, biophysics and structure-function analysis as well as genomics. Key publications from Dr. Wall have had broad impact and have been cited over 1,570 times. Prior to joining Verenium, Dr. Wall was a Howard Hughes research fellow for his post-doctoral fellowship. Dr. Wall received a Ph.D. from the University of Texas Southwestern Medical Center in Dallas and received a Bachelor of Science in Chemistry from the University of Texas at Austin.

 back to top

David Weiner
Vice President, R&D Strategy, Innovation & Partnerships

David Weiner joined Verenium in 1997 as a Senior Scientist and has held a variety of R&D positions in his 14 years with the Company and played a pivotal role in the development of Verenium's technology platform, product portfolio and pipeline.  He was named Vice President R&D Strategy, Innovation & Partnerships in March 2011. Prior to joining Verenium, Dr. Weiner pursued research fellowships at the Scripps Research Institute in La Jolla, CA and at Amherst College, MA.  He is a frequent speaker at industry conferences, has published over 20 peer-reviewed scientific papers, and is an inventor on over 30 published patent applications.  Dr. Weiner received his Bachelors in Science and his Ph.D. in Chemistry from the University of Leicester in the United Kingdom.

 back to top

Verenium harnesses the power of enzymes to create a broad range of specialty products that meet high-value commercial needs. Verenium's world class R&D organization is renowned for its capabilities in the rapid screening, identification, and expression of enzymes that act as the catalysts of biochemical reactions.